Cronus Pharma draws PE interest four years after failed Aurobindo deal
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Cronus Pharma draws PE interest four years after failed Aurobindo deal

Cronus Pharma draws PE interest four years after failed Aurobindo deal

By Debjyoti Roy

  • 13 Aug 2025
Pro
Cronus Pharma draws PE interest four years after failed Aurobindo deal
Credit: Pexels

Cronus Pharma, an animal healthcare company that top Indian drugmaker Aurobindo Pharma wanted to acquire in 2021 before .........

New to VCCircle.com?

Subscribe to VCCircle PRO and get privileged access to exclusive curated articles!

Already a VCCircle PRO member? Click here to log in.
Advertisement

Related Articles

Premium
KKR set to inject more capital into India healthcare portfolio firm

Healthcare

KKR set to inject more capital into India healthcare portfolio firm

Premium
Stellaris-backed radiology AI firm CARPL.ai adding new investor to cap table

Healthcare

Stellaris-backed radiology AI firm CARPL.ai adding new investor to cap table

Pro
Samara-backed Marengo looks to stitch more hospital acquisitions

Healthcare

Samara-backed Marengo looks to stitch more hospital acquisitions

Premium
Tata Capital's healthcare PE arm marks first close for Fund III

Healthcare

Tata Capital's healthcare PE arm marks first close for Fund III

ChrysCapital inks $159 mn control deal for Novartis India, makes open offer

Healthcare

ChrysCapital inks $159 mn control deal for Novartis India, makes open offer

Premium
Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays

Healthcare

Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays

Pro
KKR-backed Healthium in advanced talks for controlling stake in smaller peer

Healthcare

KKR-backed Healthium in advanced talks for controlling stake in smaller peer

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW
Advertisement
Advertisement